Making Sense of Next-Generation Sequencing Data
Illumina added Moleculo Technology to its technology page on its website. Illumina acquired the San Francisco based startup company founded by Stephen quake’s members Michael Kertesz and Dmitry Pushkarev in late 2012. All one initially knew was Moleculo Technology offers long reads using existing Illumina sequencers like HiSeq. After Plant and Animal Genomes conference, a bit [...]
Illumina announced the fourth quarter financial results yesterday. Illumina’s revenue during the fourth quarter of 2012 is $309 million, which is a 24% increase compared to the revenue of fourth quarter of 2011. Overall in the year 2012, Illumina’s revenue increased 9% from $1.06 billion in year 2011 to $1.15 billion in the year 2012. [...]
Xconomy’s Luke Timmerman interviewed Illumina CEO during last week’s JP Morgan Healthcare 2013 meeting and published the interview today at Xconmomy. The interview is a long one with Illumina’s CEO discussing a wide range of issues on next-gen sequencing including Illumina’s recent acquisitions Verinata Health and Moleculo. Here is a gist of the Illumin CEO’s comments on its recent acquisitions, [...]
Last week at the JMP 2013 Illumina announced the acquisition of San Francisco based Moleculo Inc. Moleculo, the company and its technology has been mysterious with little information known. All we know till now is that Moleculo is founded by Michael Kertesz and Dmitry Pushkarev, both alumini of Stephen Quake’s lab at Stanford. Moleculo has [...]
Illumina announced at the JP Morgan Healthcare Conference (JMP2013) that it has acquired San Francisco based Mocleculo. Moleculo, the sequencing startup company (with not much information in the web), is a product of Stanford University’s sequencing pioneer Stephen Quake. Michael Kertesz, a former postdoc at Stephen Quake’s lab, is the CEO and one of the co-founders [...]
Illumina announced a bunch of improvements one can expect in the future for its benchtop sequencer MiSeq and its big sequencer HiSeq 2500. Longer reads and more amount of data per run . Announcing the improvements at the JMP 2013, Illumina said its “new ordered array flow cell design will increase cluster density, enable higher [...]
What a difference a year makes for Illumina. Unlike last year, Illumina has started this year on a strong foot; Roche chief says Illumina is not a must have, but nice to have and Illumina announces the acquisition of Verinata Health, a non-invasive prenatal testing company. The year 2012 was a busy year for many personal [...]
Illumina announced that it will be acquiring Verinata Health, a leading provider of non-invasive pre-natal tests for identifying fetal chromosomal abnormalities. As per the acquisition deal, Illumina will pay $350 million plus up to $100 million through 2015. Verinata Health, the California based company, has a product verifi prenatal test that can test pregnant woman’s blood and [...]
BGI announces that US federal govt, Committee on Foreign Investment in the United States (“CFIUS”), has cleared BGI’s acquisition of US sequencing company Complete Genomics. In September, BGI-Shenzhen, the leading Chinese company in offering sequencing services announced that it is acquiring California based Complete Genomics for about $117.6 million. In November, Illumina got in to the acquisition picture [...]
